Penumbra: FDA 510(k) Clearances, Shared Predicate Lineage, and Recall History (2005 to 2026)

Consolidated U.S. FDA 510(k) premarket clearance cohort in Cardiovascular (primary filing hub: CA) reconciled with CDRH and openFDA historical recall notices from 2005 to 2026.

Review 88 FDA 510(k) clearances, 12 recalled K-numbers, and 12 cumulative 1976 to 2026 CDRH recall notices for Penumbra on Predicate Ledger.

Reconciled U.S. FDA 510(k) and Recall Summary for Penumbra
Regulatory MetricVerified Value
Entity ClassificationFDA 510(k) Applicant Manufacturer
Clinical Advisory SpecialtyCardiovascular (Panel CV)
Cleared FDA 510(k) Submissions (1976 to 2026)88 clearances (88 California, 100.0%)
Cleared 510(k)s Linked to a Recall Notice12 K-numbers (13.64% of cleared cohort)
Cumulative Historical Recall Notices (1976 to 2026)12 notices (5 Class I, 7 Class II, 0 Class III)
Currently Open vs Historical Recall StatusCumulative 1976 to 2026 FDA archive total (12 notices); verify live open vs terminated status per notice in dossier
Implantable and Life-Sustaining Clearances11 implantable (12.5%) and 0 life-sustaining
Median FDA 510(k) Review Duration92 days (90th percentile: 222 days)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Penumbra across sibling Meru public-data platforms.

Cumulative recall counts span 1976 to 2026 across U.S. FDA CDRH and openFDA public archives and combine closed historical notices with any currently open field actions. Browse all device cohorts, 20 clinical specialties, Shared 510(k) Predicate Lineage Stage, or reconciliation methodology.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.